TESTBANK
PharmacotherapeuticsforAdvanced PracticeNurse Prescribers, 6th Edition
d
s d
s ds sd ds ds ds
Author: Teri Moser Woo and Wendy L. Wright
ds d s d s d s d s ds d s
, TABLE OF CONTENT d s d s
Chapter d s 1. d s The Role of the Advanced Practice Nurse as Prescriber ............................... 4
d s d s d s d s d s d s d s d s
Chapter d s 2. d s Review of Basic Principles of Pharmacology .......................................................... 5
d s d s d s d s d s
Chapter d s 3. d s Rational Drug Selection ...................................................................................................... 11
d s d s
Chapter d s 4. d s Legal and Professional Issues in Prescribing .......................................................... 14
d s d s d s d s d s d s
Chapter d s 5. d s Adverse Drug Reactions ...................................................................................................... 16
d s d s d s
Chapter d s 6. d s An Introduction to Pharmacogenomics........................................................................... 19
d s d s d s
Chapter d s 7. d s Nutrition and Nutraceuticals .............................................................................................. 22
d s d s
Chapter d s 8. d s Herbal Therapies .................................................................................................................... 28
d s
Chapter d s 9. d s Cannabis .................................................................................................................................... 31
Chapter 10. Pharmacoeconomics ................................................................................................................ 35
d s d s
Chapter 11. Drugs Affecting the Autonomic Nervous System ................................................ 38
d s d s d s d s d s d s d s
Chapter 12. Drugs Affecting the Central Nervous System ...................................................... 45
d s d s d s d s d s d s d s
Chapter 13. Drugs Affecting the Cardiovascular and Renal Systems .................................. 53
d s d s d s d s d s d s d s d s
Chapter 14. Drugs Affecting the Respiratory System .................................................................. 61
d s d s d s d s d s d s
Chapter 15. Drugs Affecting the Hematological System.............................................................. 65
d s d s d s d s d s d s
Chapter 16. Drugs Affecting the Immune System: Vaccines and Immunoglobulins ....... 69
d s d s d s d s d s d s d s d s d s
Chapter 17. Drugs Affecting the Immune System: Immunomodulators ................................... 75
d s d s d s d s d s d s d s d s
Chapter d s 18. d s Drugs d s Affecting d s the d s Gastrointestinal d s System ............................................................ 77
Chapter 19. Drugs Affecting the Endocrine System: Pancreatic Hormones and Antidiabetic
ds d s d s d s d s d s d s d s d s d s
dDrugs ............................................................................................................................................................... 80
s
Chapter 20. Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal
d s d s d s d s d s d s d s d s d s d s
dDrugs ............................................................................................................................................................... 83
s
Chapter 21. Drugs Affecting the Reproductive System ............................................................... 86
d s d s d s d s d s d s
Chapter 22. Drugs Affecting the Bones and Joints .................................................................. 92
d s d s d s d s d s d s d s
Chapter 23. Drugs Affecting the Integumentary System .............................................................. 96
d s d s d s d s d s d s
Chapter 24. Drugs Used to Treat Bacterial Infections .............................................................101
d s d s d s d s d s d s d s d s
Chapter d s 25. d s Drugs Used to Treat Viral, Fungal, and Protozoal Infections ..................105
d s d s d s d s d s d s d s d s d s
Chapter d s 26. d s Drugs Used to Treat Inflammatory Processes ...................................................... 108
d s d s d s d s d s
Chapter d s 27. d s Drugs Used to Treat Eye and Ear Disorders ...............................................111
d s d s d s d s d s d s d s
Chapter d s 28. d s Anemia ...................................................................................................................................113
Chapter d s 29. d s Anxiety d s and d s Depression ..................................................................................................116
Chapter d s 30. d s Attention Deficit-Hyperactivity Disorder ........................................................................120
d s d s
Chapter d s 31. d s Asthma and Allergy ........................................................................................................122
d s d s d s
Chapter d s 32. d s Chronic Obstructive Pulmonary Disease .....................................................................125
d s d s d s
Chapter d s 33. d s Contraception ..........................................................................................................................127
Chapter 34. d s d s COVID-19: Acute and Chronic ...................................................................................130
d s d s d s
Chapter 35. d s d s Dermatological Conditions..................................................................................................134
d s
Chapter 36. d s d s Diabetes Management .........................................................................................................138
d s
Chapter 37. d s d s Gastroesophageal Reflux and Peptic Ulcer Disease ............................................146
d s d s d s d s d s
Chapter 38. d s d s Headaches ...............................................................................................................................149
Chapter d s 39. d s Heart d s Failure ........................................................................................................................153
,Chapter 40.d s d s HIV d s Disease d s and d s Acquired d s Immunodeficiency d s Syndrome ....................................158
Chapter d s 41. d s Menopausal Hormone Therapy .......................................................................................161
d s d s
Chapter d s 42. d s Hyperlipidemia .......................................................................................................................164
Chapter d s 43. d s Hypertension ...........................................................................................................................169
Chapter d s 44. d s Hyperthyroidism and Hypothyroidism ...........................................................................174
d s d s
Chapter d s 45. d s Obesity ....................................................................................................................................177
Chapter d s 46. d s Pain Management: Acute and Chronic Pain.........................................................181
d s d s d s d s d s
Chapter d s 47. d s Pneumonia ..............................................................................................................................185
Chapter d s 48. d s Sexually Transmitted Diseases and Vaginitis ..........................................................187
d s d s d s d s
Chapter d s 49. d s Substance Use Disorders .................................................................................................190
d s d s
Chapter d s 50. d s Tuberculosis ............................................................................................................................195
Chapter 51. Upper Respiratory Tract Infection, Pharyngitis, Sinusitis, Otitis Media, and Otitis
ds d s d s d s d s d s d s d s d s d s d s
dExterna197 Chapter 52. Urinary Tract Infections ...........................................................................200
s ds d s d s d s d s
Chapter d s 53. d s Women as Patients ..........................................................................................................203
d s d s
Chapter d s 54. d s Men as Patients ...............................................................................................................207
d s d s
Chapter d s 55. d s Pediatric Patients .................................................................................................................209
d s
Chapter d s 57. d s Geriatric Patients ..................................................................................................................213
d s
, Woo 1
Pharmacotherapeutics for APN Prescribers, Ch01
Chapter 1. The Role
d s d s d s d s of the Advanced Practice Nurse as Prescriber
d s d s d s d s d s d s
MULTIPLE d s CHOICE
1. Nurse practitioner prescriptive authority is regulated by:
d s d s d s d s d s d s
A. The National Council of State Boards of Nursing
d s d s d s d s d s d s d s
B. The U.S. Drug Enforcement Administration
d s d s d s d s
C. The State Board of Nursing for each state
d s d s d s d s d s d s d s
D. The State Board of Pharmacy d s d s d s d s
ANS: C PTS: 1
2. The benefits to the patient of having an advanced practice registered nurse (APRN)
ds ds ds ds ds ds ds ds ds ds ds ds
prescriber include:
ds ds
A. Nurses know more about pharmacology than other prescribers because they take
ds ds ds ds ds ds ds ds ds ds
it both in
ds their
d s basicd s nursing program and in their d s d s d s d s d s d s d s d s d s d s d s d s d s d s
APRN d s d s
program.
B. Nurses care for the patient from a holistic approach and include the patient
ds ds ds ds ds ds ds ds ds ds ds ds
in decision-making regarding their care.
ds ds ds ds ds
C. APRNs are less likely to prescribe narcotics and other controlled substances.
d s d s d s d s d s d s d s d s d s ds
D. APRNs are able to prescribe independently in all states, whereas a
d s d s d s d s d s d s d s d s d s d s
physician’s assistant needs to have a physician supervising their practice. d s d s d s d s d s d s d s d s d s
ANS: B PTS: 1
3. Clinical judgment in prescribing includes:
d s d s d s d s
A. Factoring in the cost to the patient of the medication prescribed
d s d s d s d s d s d s d s d s d s d s
B. Always prescribing the newest medication available for the disease process
d s d s d s d s d s d s d s d s ds
C. Handing out drug samples to poor patients d s d s d s d s d s d s
D. Prescribing all generic medications to cut costs d s d s d s d s d s d s
ANS: A PTS: 1
4. The process for choosing an effective drug for a disorder includes:
d s d s d s d s d s d s d s d s d s d s
A. Asking the patient what drug they think would work
d s best for them d s d s d s d s d s d s d s d s d s d s d s
B. Consulting nationally recognized guidelines for disease management d s d s d s d s d s ds
C. Prescribing medications that are available as samples before writing a d s d s d s d s d s d s d s d s d s
prescription
d s
D. Following U.S. d s d s Drug d s Enforcement d s Administration d s guidelines d s for prescribing
ds
ANS: B PTS: 1
5. Nonintentional nonadherence of drug therapy may d s d s d s d s d s d s occur d s due d s to:
A. Belief that medication does not work d s d s d s d s d s
B. Adverse drug reactions d s d s
C. Chronic conditions that require daily therapy d s d s d s d s d s
D. Forgetfulness or distraction d s ds
ANS: D PTS: 1
PharmacotherapeuticsforAdvanced PracticeNurse Prescribers, 6th Edition
d
s d
s ds sd ds ds ds
Author: Teri Moser Woo and Wendy L. Wright
ds d s d s d s d s ds d s
, TABLE OF CONTENT d s d s
Chapter d s 1. d s The Role of the Advanced Practice Nurse as Prescriber ............................... 4
d s d s d s d s d s d s d s d s
Chapter d s 2. d s Review of Basic Principles of Pharmacology .......................................................... 5
d s d s d s d s d s
Chapter d s 3. d s Rational Drug Selection ...................................................................................................... 11
d s d s
Chapter d s 4. d s Legal and Professional Issues in Prescribing .......................................................... 14
d s d s d s d s d s d s
Chapter d s 5. d s Adverse Drug Reactions ...................................................................................................... 16
d s d s d s
Chapter d s 6. d s An Introduction to Pharmacogenomics........................................................................... 19
d s d s d s
Chapter d s 7. d s Nutrition and Nutraceuticals .............................................................................................. 22
d s d s
Chapter d s 8. d s Herbal Therapies .................................................................................................................... 28
d s
Chapter d s 9. d s Cannabis .................................................................................................................................... 31
Chapter 10. Pharmacoeconomics ................................................................................................................ 35
d s d s
Chapter 11. Drugs Affecting the Autonomic Nervous System ................................................ 38
d s d s d s d s d s d s d s
Chapter 12. Drugs Affecting the Central Nervous System ...................................................... 45
d s d s d s d s d s d s d s
Chapter 13. Drugs Affecting the Cardiovascular and Renal Systems .................................. 53
d s d s d s d s d s d s d s d s
Chapter 14. Drugs Affecting the Respiratory System .................................................................. 61
d s d s d s d s d s d s
Chapter 15. Drugs Affecting the Hematological System.............................................................. 65
d s d s d s d s d s d s
Chapter 16. Drugs Affecting the Immune System: Vaccines and Immunoglobulins ....... 69
d s d s d s d s d s d s d s d s d s
Chapter 17. Drugs Affecting the Immune System: Immunomodulators ................................... 75
d s d s d s d s d s d s d s d s
Chapter d s 18. d s Drugs d s Affecting d s the d s Gastrointestinal d s System ............................................................ 77
Chapter 19. Drugs Affecting the Endocrine System: Pancreatic Hormones and Antidiabetic
ds d s d s d s d s d s d s d s d s d s
dDrugs ............................................................................................................................................................... 80
s
Chapter 20. Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal
d s d s d s d s d s d s d s d s d s d s
dDrugs ............................................................................................................................................................... 83
s
Chapter 21. Drugs Affecting the Reproductive System ............................................................... 86
d s d s d s d s d s d s
Chapter 22. Drugs Affecting the Bones and Joints .................................................................. 92
d s d s d s d s d s d s d s
Chapter 23. Drugs Affecting the Integumentary System .............................................................. 96
d s d s d s d s d s d s
Chapter 24. Drugs Used to Treat Bacterial Infections .............................................................101
d s d s d s d s d s d s d s d s
Chapter d s 25. d s Drugs Used to Treat Viral, Fungal, and Protozoal Infections ..................105
d s d s d s d s d s d s d s d s d s
Chapter d s 26. d s Drugs Used to Treat Inflammatory Processes ...................................................... 108
d s d s d s d s d s
Chapter d s 27. d s Drugs Used to Treat Eye and Ear Disorders ...............................................111
d s d s d s d s d s d s d s
Chapter d s 28. d s Anemia ...................................................................................................................................113
Chapter d s 29. d s Anxiety d s and d s Depression ..................................................................................................116
Chapter d s 30. d s Attention Deficit-Hyperactivity Disorder ........................................................................120
d s d s
Chapter d s 31. d s Asthma and Allergy ........................................................................................................122
d s d s d s
Chapter d s 32. d s Chronic Obstructive Pulmonary Disease .....................................................................125
d s d s d s
Chapter d s 33. d s Contraception ..........................................................................................................................127
Chapter 34. d s d s COVID-19: Acute and Chronic ...................................................................................130
d s d s d s
Chapter 35. d s d s Dermatological Conditions..................................................................................................134
d s
Chapter 36. d s d s Diabetes Management .........................................................................................................138
d s
Chapter 37. d s d s Gastroesophageal Reflux and Peptic Ulcer Disease ............................................146
d s d s d s d s d s
Chapter 38. d s d s Headaches ...............................................................................................................................149
Chapter d s 39. d s Heart d s Failure ........................................................................................................................153
,Chapter 40.d s d s HIV d s Disease d s and d s Acquired d s Immunodeficiency d s Syndrome ....................................158
Chapter d s 41. d s Menopausal Hormone Therapy .......................................................................................161
d s d s
Chapter d s 42. d s Hyperlipidemia .......................................................................................................................164
Chapter d s 43. d s Hypertension ...........................................................................................................................169
Chapter d s 44. d s Hyperthyroidism and Hypothyroidism ...........................................................................174
d s d s
Chapter d s 45. d s Obesity ....................................................................................................................................177
Chapter d s 46. d s Pain Management: Acute and Chronic Pain.........................................................181
d s d s d s d s d s
Chapter d s 47. d s Pneumonia ..............................................................................................................................185
Chapter d s 48. d s Sexually Transmitted Diseases and Vaginitis ..........................................................187
d s d s d s d s
Chapter d s 49. d s Substance Use Disorders .................................................................................................190
d s d s
Chapter d s 50. d s Tuberculosis ............................................................................................................................195
Chapter 51. Upper Respiratory Tract Infection, Pharyngitis, Sinusitis, Otitis Media, and Otitis
ds d s d s d s d s d s d s d s d s d s d s
dExterna197 Chapter 52. Urinary Tract Infections ...........................................................................200
s ds d s d s d s d s
Chapter d s 53. d s Women as Patients ..........................................................................................................203
d s d s
Chapter d s 54. d s Men as Patients ...............................................................................................................207
d s d s
Chapter d s 55. d s Pediatric Patients .................................................................................................................209
d s
Chapter d s 57. d s Geriatric Patients ..................................................................................................................213
d s
, Woo 1
Pharmacotherapeutics for APN Prescribers, Ch01
Chapter 1. The Role
d s d s d s d s of the Advanced Practice Nurse as Prescriber
d s d s d s d s d s d s
MULTIPLE d s CHOICE
1. Nurse practitioner prescriptive authority is regulated by:
d s d s d s d s d s d s
A. The National Council of State Boards of Nursing
d s d s d s d s d s d s d s
B. The U.S. Drug Enforcement Administration
d s d s d s d s
C. The State Board of Nursing for each state
d s d s d s d s d s d s d s
D. The State Board of Pharmacy d s d s d s d s
ANS: C PTS: 1
2. The benefits to the patient of having an advanced practice registered nurse (APRN)
ds ds ds ds ds ds ds ds ds ds ds ds
prescriber include:
ds ds
A. Nurses know more about pharmacology than other prescribers because they take
ds ds ds ds ds ds ds ds ds ds
it both in
ds their
d s basicd s nursing program and in their d s d s d s d s d s d s d s d s d s d s d s d s d s d s
APRN d s d s
program.
B. Nurses care for the patient from a holistic approach and include the patient
ds ds ds ds ds ds ds ds ds ds ds ds
in decision-making regarding their care.
ds ds ds ds ds
C. APRNs are less likely to prescribe narcotics and other controlled substances.
d s d s d s d s d s d s d s d s d s ds
D. APRNs are able to prescribe independently in all states, whereas a
d s d s d s d s d s d s d s d s d s d s
physician’s assistant needs to have a physician supervising their practice. d s d s d s d s d s d s d s d s d s
ANS: B PTS: 1
3. Clinical judgment in prescribing includes:
d s d s d s d s
A. Factoring in the cost to the patient of the medication prescribed
d s d s d s d s d s d s d s d s d s d s
B. Always prescribing the newest medication available for the disease process
d s d s d s d s d s d s d s d s ds
C. Handing out drug samples to poor patients d s d s d s d s d s d s
D. Prescribing all generic medications to cut costs d s d s d s d s d s d s
ANS: A PTS: 1
4. The process for choosing an effective drug for a disorder includes:
d s d s d s d s d s d s d s d s d s d s
A. Asking the patient what drug they think would work
d s best for them d s d s d s d s d s d s d s d s d s d s d s
B. Consulting nationally recognized guidelines for disease management d s d s d s d s d s ds
C. Prescribing medications that are available as samples before writing a d s d s d s d s d s d s d s d s d s
prescription
d s
D. Following U.S. d s d s Drug d s Enforcement d s Administration d s guidelines d s for prescribing
ds
ANS: B PTS: 1
5. Nonintentional nonadherence of drug therapy may d s d s d s d s d s d s occur d s due d s to:
A. Belief that medication does not work d s d s d s d s d s
B. Adverse drug reactions d s d s
C. Chronic conditions that require daily therapy d s d s d s d s d s
D. Forgetfulness or distraction d s ds
ANS: D PTS: 1
